Author

Daniel Z. Wang

Observed names: DANIEL Z. WANG, Daniel Z Wang

Observed institutions: Tulane University, Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, University of California, San Francisco, University of Virginia Health System, Texas Department of Public Safety, University of Virginia, University of California, Davis

OpenAlex ID: A5074765404

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

1998 · John D. McConnell, Reginald Bruskewitz, et al. · New England Journal of Medicine · 1,123

Chronic Treatment With Finasteride Daily Does Not Affect Spermatogenesis or Semen Production in Young Men

1999 · JAMES W. OVERSTREET, VIVIAN L. FUH, et al. · The Journal of Urology · 144

Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia

1999 · Reginald Bruskewitz, Cynthia J. Girman, et al. · Urology · 91

MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen1

1997 · Jules I. Schwartz, Wesley K. Tanaka, et al. · The Journal of Clinical Endocrinology & Metabolism · 37

MK-386, an Inhibitor of 5 alpha-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum Without Affecting Dihydrotestosterone Concentrations in Semen

1997 · Jules I. Schwartz, Wesley K. Tanaka, et al. · Obstetrical & Gynecological Survey · 12

Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.

2007 · Fred G Freitag, Grace Forde, et al. · PubMed · 9

Analyzing a continuous efficacy response in a long-term trial with high dropout rate

1998 · Daniel Z. Wang, Thomas J. Cook · Controlled Clinical Trials

Works count: 7

Citation count: 1,416

H-index: 6

I10-index: 5